Clinical Trials Browser

Phase 1 × Neoplasms × dubermatinib × Clear all

NCT02729298 2023-11-14

First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors

Phase 1 Completed

GastrointestinalGynecologic

Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms